Colgate-Palmolive Company Website

Colgate-Palmolive Company

NYSE-CL

Basic

  • Market Cap

    $80.46B

  • EV

    $88.23B

  • Shares Out

    820.44M

  • Revenue

    $19.75B

  • Employees

    34,000

Margins

  • Gross

    59%

  • EBITDA

    23.82%

  • Operating

    20.83%

  • Pre-Tax

    19.23%

  • Net

    13.22%

  • FCF

    15.3%

Returns (5Yr Avg)

  • ROA

    14.86%

  • ROTA

    -132.7%

  • ROE

    597.25%

  • ROCE

    34.07%

  • ROIC

    24.85%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $100.01

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,310M

  • Net Debt

    $7,379M

  • Debt/Equity

    14.08

  • EBIT/Interest

    14.14

Growth (CAGR)

  • Rev 3Yr

    5.72%

  • Rev 5Yr

    5.07%

  • Rev 10Yr

    1.26%

  • Dil EPS 3Yr

    0.44%

  • Dil EPS 5Yr

    3.29%

  • Dil EPS 10Yr

    3.1%

  • Rev Fwd 2Yr

    3.93%

  • EBITDA Fwd 2Yr

    7.39%

  • EPS Fwd 2Yr

    9.12%

  • EPS LT Growth Est

    8.54%

Dividends

  • Yield

  • Payout

    60.68%

  • DPS

    $1.92

  • DPS Growth 3Yr

    2.94%

  • DPS Growth 5Yr

    2.71%

  • DPS Growth 10Yr

    3.51%

  • DPS Growth Fwd 2Yr

    4.82%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

15,693

16,471

17,421

17,967

19,457

19,752

Total Revenues % Chg.

1%

5%

5.8%

3.1%

8.3%

7.7%

Cost of Goods Sold, Total

6,357

6,454

7,046

7,719

8,130

8,098

Gross Profit

9,336

10,017

10,375

10,248

11,327

11,654

Selling General & Admin Expenses, Total

5,616

6,093

6,477

6,625

7,237

7,390

Other Operating Expenses

76

136

85

41

148

149

Other Operating Expenses, Total

5,692

6,229

6,562

6,666

7,385

7,539

Operating Income

3,644

3,788

3,813

3,582

3,942

4,115

Interest Expense, Total

-192

-183

-117

-167

-287

-291

Interest And Investment Income

47

19

17

14

55

55

Net Interest Expenses

-145

-164

-100

-153

-232

-236

Income (Loss) On Equity Invest.

9

12

12

12

17

17

EBT, Excl. Unusual Items

3,508

3,636

3,725

3,441

3,727

3,896

Restructuring Charges

-132

13

-110

-32

-62

Merger & Related Restructuring Charges

-24

-2

-19

Impairment of Goodwill

-332

Gain (Loss) On Sale Of Investments

-51

8

22

-11

-11

Gain (Loss) On Sale Of Assets

47

Asset Writedown

-571

-389

Legal Settlements

-267

Other Unusual Items

-75

-25

-25

EBT, Incl. Unusual Items

3,301

3,647

3,087

2,660

3,392

3,798

Income Tax Expense

774

787

749

693

937

1,028

Earnings From Continuing Operations

2,527

2,860

2,338

1,967

2,455

2,770

Extraordinary Item & Accounting Change

Minority Interest

-160

-165

-172

-182

-155

-159

Net Income

2,367

2,695

2,166

1,785

2,300

2,611

Net Income to Common Incl Extra Items

2,367

2,695

2,166

1,785

2,300

2,611

Net Income to Common Excl. Extra Items

2,367

2,695

2,166

1,785

2,300

2,611

Total Shares Outstanding

854.7

849.9

840.5

830.2

821.4

820.4

Weighted Avg. Shares Outstanding

859.1

856.8

845

836.4

827.4

825.3

Weighted Avg. Shares Outstanding Dil

861.1

859.3

848.3

838.8

829.2

827.4

EPS

2.8

3.1

2.6

2.1

2.8

3.2

EPS Diluted

2.8

3.1

2.6

2.1

2.8

3.2

EBITDA

4,163

4,327

4,369

4,127

4,509

4,704

Effective Tax Rate

23.4%

21.6%

24.3%

26.1%

27.6%

27.1%